Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
companies in this sector in UNITED STATES :
sales of $48.62 billion
of which 78%
was Innovative Medicines),
of which 76%
was Biopharma), and
of which 46%
Roche Holding Aktiengesellschaft reported sales of $61.89 billion
December of 2019.
increase of 6.4%
versus 2018, when the company's sales were $58.19 billion.
This was the fourth straight year of sales growth at Roche Holding Aktiengesellschaft.
Sales of Pharmaceuticals saw an increase
8.5% in 2019, from
$45.01 billion to $48.85 billion.
Not all segments of Roche Holding Aktiengesellschaft experienced an increase in sales in 2019:
sales of Diagnostics fell 1.1% to $13.04 billion.